Stock Doctor

Stock Doctor Stock Doctor is Australia’s leading DIY stock research and portfolio platform, built on Dr Merv Lincoln’s proven investment methodology. Growth Fund.

Get independent insights, expert recommendations, and powerful tools. Explore more: https://www.stockdoctor.com.au/ At Lincoln Indicators, we invest in facts, not opinions. We offer investors the option to invest in stocks themselves with Stock Doctor - one of Australia’s premier stock research, ratings and insights tool with portfolio tracker and manager features too. For investors who want us to

manage their investments, we do it for them through our Managed Funds: Australian Income Fund, Australian Growth Fund and U.S. We help investors invest in the numbers with confidence, control and peace of mind.

31/08/2026

This week on Taking Stock, Kien Trinh and Charlie Song unpack softer FY27 earnings expectations and contrasting reporting-season reactions across retail, telcos and industrials.

They assess results from retail giants Wesfarmers (ASX:WES) and Lovisa (ASX:LOV), revisit the outlook for telecommunications leader Telstra (ASX:TLS) and engineering contractor Monadelphous (ASX:MND), and put global pallet-pooling provider Brambles (ASX:BXB) under the microscope.

They also explain how to easily track Star Stock updates and recommendation changes.

Watch the latest episode today: https://www.stockdoctor.com.au/insights-and-events/taking-stock-weekly-insights-28-august-2026

Wesfarmer FY26 result highlighted the challenges of meeting high investor expectations, with earnings growth across the ...
28/08/2026

Wesfarmer FY26 result highlighted the challenges of meeting high investor expectations, with earnings growth across the portfolio overshadowed by concerns around future growth and increasing investment costs.

From continued earnings growth at Bunnings and Kmart to strong contributions from Health and WesCEF, the result showcased the benefits of a diversified earnings base.

However, softer growth expectations across key divisions and rising capital expenditure became the primary focus for investors.

Join our upcoming Reporting Season Webinar as our analysts unpack the key opportunities, risks and trends emerging from this reporting season's results.

Register today to reserve your place: https://www.stockdoctor.com.au/resource/reporting-season-looking-beyond-the-numbers

Qantas' FY26 result highlighted the ongoing importance of travel demand, Loyalty earnings and fleet renewal, while also ...
28/08/2026

Qantas' FY26 result highlighted the ongoing importance of travel demand, Loyalty earnings and fleet renewal, while also demonstrating the impact higher fuel costs can have on profitability.

From growing revenue and double-digit Loyalty earnings growth to rising operating costs and increased investment in the business, Qantas' latest result provided several key insights for investors.

Join our upcoming Reporting Season Webinar as our analysts unpack the key opportunities, risks and trends emerging from this reporting season's results.

Register today to reserve your place: https://www.stockdoctor.com.au/resource/reporting-season-looking-beyond-the-numbers

26/08/2026

Reporting season is one of the most important periods on the investing calendar. But knowing what to look for, and what to ignore, makes all the difference.

Stock Doctor's Head of Research, Kien Trinh, breaks down what investors should be watching when the numbers come in, and how to cut through the noise.

Get 90 days of full Stock Doctor Signature access for $399 and save 20%. The research and insights you need, right when it matters most. Offer ends 1 September.

Discover more today: http://members.lincolnindicators.com.au/offer/purchase/report-08-2026/513

Financial health can often reveal risks that headlines miss.Using Top Shelf International (ASX: TSI) as a case study, we...
24/08/2026

Financial health can often reveal risks that headlines miss.

Using Top Shelf International (ASX: TSI) as a case study, we highlight how Financial Health can reveal risks that headlines often miss.

The warning signs were present long before the company's eventual administration.

Sometimes the biggest risks are hiding beneath the surface.

Explore the full story: https://www.stockdoctor.com.au/insights-and-events/why-financial-health-matters

24/08/2026

This week on Taking Stock, Matthew Swartz and Jason Yin unpack a volatile week shaped by Iran, higher oil prices and President Trump, before turning to a busy reporting season featuring JB Hi-Fi (ASX:JBH), Super Retail Group (ASX:SUL), Universal Store (ASX:UNI), CSL (ASX:CSL), Cochlear (ASX:COH), Pro Medicus (ASX:PME), SKS Technologies (ASX:SKS), Codan (ASX:CDA) and Brambles (ASX:BXB).

They also put BHP’s (ASX:BHP) growing copper exposure under the microscope and explore why a strong result can still disappoint the market when expectations are even higher.

Watch the latest episode today : https://www.stockdoctor.com.au/insights-and-events/taking-stock-weekly-insights-21-august-2026

What does Medibank's latest result reveal about Australia's private health insurance sector?From slowing policyholder gr...
21/08/2026

What does Medibank's latest result reveal about Australia's private health insurance sector?

From slowing policyholder growth and rising competition to resilient margins and healthcare expansion, Medibank's FY26 result highlighted several themes investors are watching closely.

Join our upcoming Reporting Season Webinar as our analysts unpack the key opportunities, risks and developments emerging from Medibank's latest result.

Register now to reserve your place: https://www.stockdoctor.com.au/resource/reporting-season-looking-beyond-the-numbers

Super Retail Group (ASX: SUL) delivered a stronger-than-expected FY26 result, with margin improvements at Rebel and BCF ...
21/08/2026

Super Retail Group (ASX: SUL) delivered a stronger-than-expected FY26 result, with margin improvements at Rebel and BCF helping drive profit above expectations.

While Supercheap Auto remained a standout performer, improved pricing discipline at Rebel and stronger product margins at BCF were key contributors to the result.

Looking beyond the numbers can reveal a different story.

Join our upcoming Reporting Season Webinar as our analysts explore the key takeaways from Super Retail Group's FY26 result and what investors should be watching next.

Register now to reserve your place: https://www.stockdoctor.com.au/resource/reporting-season-looking-beyond-the-numbers

21/08/2026

Reporting season moves fast, and separating signal from noise takes more than a scan of the headlines. Stock Doctor's objective framework lets you assess a stock's return on equity, margins, outlook and risk.

Signature members go a step further, with direct access to our analysts to support their research.

It's your chance to talk through the numbers behind a stock or get context on the year ahead, straight from the people who research it.

Start your free trial of Stock Doctor Signature today to experience it for yourself: https://members.lincolnindicators.com.au/SignUp?offercode=website-trial

Has Breville's growth story entered a new phase?Breville delivered a record FY26 result, with strong sales growth across...
20/08/2026

Has Breville's growth story entered a new phase?

Breville delivered a record FY26 result, with strong sales growth across global markets despite ongoing tariff uncertainty. The company has reduced its reliance on Chinese manufacturing for the US market, while margins improved and newer markets continued to gain momentum.

While the result highlighted the resilience of the business, investors will be watching closely to see whether strong sales growth can translate into faster earnings growth through FY27.

Join our upcoming Reporting Season Webinar as our analysts unpack the key insights, opportunities and risks emerging from this year's reporting season.

Register today : https://www.stockdoctor.com.au/resource/reporting-season-looking-beyond-the-numbers

Address

HWT Tower, Level 17, 40 City Road, Southbank
Melbourne, VIC
3006

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Telephone

1300 676 333

Website

Alerts

Be the first to know and let us send you an email when Stock Doctor posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Stock Doctor:

Shortcuts

Featured

Share

Category